Life Science Company
Cumberland Pharmaceuticals has acquired 1 company, including 1 in the last 5 years.
Cumberland Pharmaceuticals’ largest acquisition to date was in 2018, when it acquired Theravance Biopharma - VIBATIV for $20M. Cumberland Pharmaceuticals has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).
Join Mergr and gain access to Cumberland Pharmaceuticals’ M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.
M&A Total Activity1
- M&A Buy Activity1
- Total Sectors Invested 1
- Total Countries Invested 1
- M&A Buy/Sell Connections 1